Blue Water Solutions, Inc. completed the acquisition of Substantially all of Pathogen Detection Systems Business of Nephros, Inc..
November 14, 2022
Share
Blue Water Solutions, Inc. entered into a definitive agreement to acquire Substantially all of Pathogen Detection Systems Business of Nephros, Inc. (NasdaqCM:NEPH) for 0.001 million on October 4, 2022. BWSI will make a nominal cash payment at the closing of $1,000 and will assume certain liabilities of the PDS Business from and after the date of Closing. In addition, for a period of seven years commencing in 2023, Nephros will be entitled to share a portion of gross profits from the commercialization of the company’s PDS products and technologies. The transaction is subject to customary closing conditions. The transaction is expect to close in mid November. Christopher J. Melsha of Fredrikson & Byron P.A. acted as legal advisor to Nephros, Inc. John-Patrick Curran of Sive, Paget & Riesel, P.C. acted as legal advisor to Blue Water Solutions, Inc.
Blue Water Solutions, Inc. completed the acquisition of Substantially all of Pathogen Detection Systems Business of Nephros, Inc. (NasdaqCM:NEPH) on November 15, 2022.
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. It operates through the Water Filtration segment. In the medical markets, it sells water filtration products. In the commercial markets, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. Its products are marketed primarily to the food service, hospitality, convenience store, and health care markets. These commercial products are also marketed into medical markets, as supplemental filtration to its medical filters. The Companyâs filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
NEPHROS, INC. 
